Rachel K. King, Director at NOVAVAX INC (NVAX), sold 4,150 shares at $9.02 ($37K) on 2024-12-13, disclosed to the SEC on 2025-01-02.
Open-market sale of $37k NVAX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| NVAX | BUY | 2019-03-28 | $34K | — | Filing → |